Spruce Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Spruce Biosciences

14/11/2022 12:00

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 53 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 48 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had fallen by 15.3% this
quarter and lost 74.0% so far this year.
    * The company reported a quarterly loss of $11.43 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.52          -0.51          Beat
 Mar. 31 2022      -0.46          -0.50          Missed
 Dec. 31 2021      -0.54          -0.39          Beat